Welcome to Stem Cell Therapy Abu Dhabi
Stem Cell Therapy Abu Dhabi is the first regenerative Medicine center in the United Arab Emirates. Featuring top and the most advanced facilities for treatment, equipment and diagnosis, and with a team of renowned specialists and medical personnel at the helm, the clinic is poised to usher in a new healthcare era in UAE.
The center's unique expertise that combines Professors in specialties like haematology-oncology with renowned surgeons specialized in regenerative medicine together with a large team of specialists in one of the leading hospitals in the world makes it remarkable. Stem Cell Therapy Abu Dhabi has treated over 800 patients with different incurable diseases with promising results.
Stem cell therapy for:
A stem cell (SCs) is a significant portion of mononuclear cells that is capable to divide (self replicate) for indefinite periods of time - often throughout the entire life of the organism. They are necessary for living while they provide a continuous repair and renewal of tissues in the patients' body. Under the right conditions or signals, the stem cells can give rise (differentiate) to the numerous cell types needed in various systems. By means, stem cells have the ability to develop into mature cells that have characteristics, shapes and specialized functions, such as:
The autologous stem cells (aSC) are adult mononuclear cells, including the stem cell portion, obtained from the same person that will be treated. These cells are highly researched and promoted for cell therapies because:
They lack of immunologic rejection, they don't show any risk of forming tumours and they don't represent any ethical concern.
One of the major sources of aMC is the BM (bone marrow) - the so called autologous bone marrow-derived stem cells (aBM-SC).
The autologous bone marrow-derived stem cells are a heterogeneous population of cells that includes hematopoietic (HSCs) - mesenchymal stem cells (MSCs) inter alia.
The clinic's stem cell method is the Point-Of- Care method: autologous bone marrow-derived mononuclear cells transplant with on-site cell concentration for non- hematooncological diseases.
The clinic's renowned medical team is highly experienced and has an extensive professional and educational background in performing stem cell procedures. The doctors are, constantly working with patients coming from countries all around the world, therefore the communication with people of different cultures and societies is comprehensive and efficient.
George S. Kobinia, M.D.
Board certified general surgeon, cardiac, vascular and thoracic surgeon and Regenerative medicine specialist
George S. Kobinia was born in 1949 in postwar Vienna, Austria, where he also grew up. He graduated from the Vienna Medical University in 1973 and started his clinical career at the City Hospital of Lainz, Vienna, and later in Linz, where he specialized in thoracic and vascular surgery. In 1984 he was awarded the prestigious Evarts A. Graham Fellowship of the „American Association for Thoracic Surgery", which he used to work at the Massachusetts General Hospital at the University of Harvard, Boston, (1984/85). This fellowship is granted once a year to one surgeon worldwide.
In the laboratories where once the heart lung machine was invented he wrote his professorial dissertation on prostaglandins metabolism of the heart during cardioplegia. After his return to Europe in 1986, Dr. Kobinia was nominated as the Head of the new department of cardiac and thoracic surgery at the Hospital Klagenfurt (toady's Klinikum Klagenfurt). Using his newly acquired experience in computing he set up an electronic data entry for surgical and clinical documentation at a time when computing was still far away from clinical every day practice.
Dr. Kobinia founded the Stem Cell Therapy Group in Vienna. He also helped to set up a clinical unit for stem cell treatment at the Wadi el Neel University Hospital in Cairo, Egypt. Together with the cardiologist Dr. HazemKhamis a method for intracoronary stem cell application was developed which not only uses the bone marrow derived stem cell concentrate but also bone marrow derived plasma, a substance, which is now more intensively researched for its pronounced vasodilatative properties.
Achievements and patents
• Development of the Kobinia Aortic Root 1997
• Development of the Kobinia Mammaria Spreader 1997
• Development of the first deendothelialised porcine stentless heart valve in cooperation with W. Hancock 1998
• St. Ekaterina University Hospital, Sofia (Prof. Tschirkov), (Description of: Early results of the simplified implantation technique for stentless valves and their application in endocarditis) 2002 - 2003
• Use of Point of Care Method for adult bone marrow derived stem cells.
• Use of bone marrow derived plasma as an adjunct to cell therapy
Why Choose Us?
UAE features high rise buildings that escape your imagination, a solid economy and cooperation with the top universities of the world. Now, this unique place has something new to offer that sets a new standard in international medicine.
For more information about Stem Cell Therapy Abu Dhabi and the treatments and procedures available, click the contact button below!